Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nulastin is a commercial-stage personal care and biotechnology company specializing in elastin replenishment solutions for hair, skin, lashes, and brows. Founded in 2016 and headquartered in Boulder, Colorado, the company leverages its proprietary, patented Elastaplex Technology, which features a synergistic blend of biodesigned proteins and signal peptides—including recombinant human elastin (sh-Polypeptide-50), keratin, and hepatocyte growth factor. These ingredients are designed to support the body's natural elastin pathways, reinforcing the hair follicle's root system to reduce shedding and promote thicker, fuller growth. Nulastin operates primarily as a direct-to-consumer brand while expanding into retail and professional medical channels, such as plastic surgery and dermatology practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nulastin.